The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D003918:Dextrothyroxine / Q000627:therapeutic use; D004562:Electrocardiography; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use; D010919:Placebos; D011422:Propionates / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000150:complications; D013223:Statistics as Topic; D013924:Thrombophlebitis / Q000150:complications; D013997:Time Factors
D000924:Anticholesteremic Agents; D004966:Estrogens, Conjugated (USP); D009539:Nicotinic Acids; D010919:Placebos; D011422:Propionates; D003918:Dextrothyroxine; D002994:Clofibrate